VEGFA and plasma cell myeloma: In our more recent study on multiple myeloma cells [13] and those conducted by Dell’Eva et al. [51] on leukemic cells, this compound was found to attenuate the expression of VEGF, which is the most prominent proangiogenic growth factor.